Dublin, Oct. 19, 2026 (GLOBE NEWSWIRE) -- "Microarray Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering. This market research report examines the global ...
A Norwegian population-based study finds that the manual mitotic count retains independent prognostic value in hormone ...
A new case report and pooled analysis of 35 prenatal cases shows that 15q duplication syndrome frequently escapes prenatal ...
OREM, UT, UNITED STATES, October 15, 2026 /EINPresswire.com/ -- Techcyte, developer of Fusion, the enterprise digital ...
Dublin, Oct. 13, 2026 (GLOBE NEWSWIRE) -- "Chromosomal Microarray Reflex Testing Global Market Report 2026" has been added to ResearchAndMarkets.com's offering. The global chromosomal microarray ...
EpiSign Inc. and Geneyx Genomex Ltd. announced a partnership to advance the integration of genomic and epigenomic analysis ...
LONDON, ON and HERZLIYA, Israel, Oct. 5, 2026 /PRNewswire/ -- EpiSignInc. and GeneyxGenomex Ltd. today announced a partnership to advance the integration of genomic and epigenomic analysis for ...
A prespecified analysis of a phase 3 trial evaluated the ability of PAM50 molecular prostate cancer subtypes to predict benefit from salvage treatment intensification.
Pacific Biosciences of California's business model struggles to gain traction versus larger, profitable competitors like Illumina. Read why PACB stock is a buy.
EpiSign Inc. today announced the launch of EpiSign METRIC 5-base, extending its comprehensive and automated episignature analysis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results